Celgene logoIn July 2013, Array announced a discovery collaboration with Celgene for an undisclosed novel inflammation pathway.

Array received an up-front payment of $11 million, and Celgene will have an exclusive option to license multiple clinical development candidates.

Array is eligible to receive up to $376 million in milestone payments along with royalties on sales of any resulting drugs.

Visit www.Celgene.com (clicking on this link will leave ArrayBioPharma.com)